MedPath

Tactile and Kinaesthetic Stimulation in Neonates With Hyperbilirubinaemia

Not Applicable
Completed
Conditions
Neonatal Hyperbilirubinemia
Interventions
Other: Massage therapy
Other: Kinaesthetic stimulation
Registration Number
NCT05077787
Lead Sponsor
Asir John Samuel
Brief Summary

Hyperbilirubinemia is the most common problem seen in neonates, owing to severe complications in their lifetime. The study design of the study is pretest - a posttest experimental design. Criterion-based purposive sampling will be used for recruiting the neonates. In the study neonates will be selected according to the selection criteria and will be allocated into two groups using computer-based randomization.The Intervention group - neonates will receive tactile and kinesthetic stimulation for 15 minutes for 3 consecutive days, 1 hour after feeding twice daily along with Phototherapy, Control group - Phototherapy alone will be given along with conventional NICU care. Total serum bilirubin will be assessed as outcome measures daily once. Transcutaneous bilirubin will be assessed after every intervention.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
68
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Experimental GroupKinaesthetic stimulationNeonates recruited in experimental group will receive massage therapy and kinaesthetic stimulation for 15 minutes along with phototherapy for consecutive days . It will be given in three phases first massage therapy will be given for 5 minutes, followed by movement of limbs for 5 minutes and then again massage therapy will be repeated for 5 minutes.
Experimental GroupMassage therapyNeonates recruited in experimental group will receive massage therapy and kinaesthetic stimulation for 15 minutes along with phototherapy for consecutive days . It will be given in three phases first massage therapy will be given for 5 minutes, followed by movement of limbs for 5 minutes and then again massage therapy will be repeated for 5 minutes.
Primary Outcome Measures
NameTimeMethod
Total Serum Bilirubin (TSB)Changes in the Total Serum Bilirubin level will be measured at baseline and at the end of three days intervention

It will measure total bilirubin level in blood of neonates

Transcutaneous Bilirubin (TcB)Changes in the Transcutaneous Bilirubin level will be measured daily for three days before and after intervention

Transcutaneous Bilirubin will measure neonatal jaundice.

Weight GainChanges in the weight will be measured at baseline and at the end of three days intervention

Weight gain will evaluate the change in neonatal weight

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Civil Hospital

🇮🇳

Ropar, Punjab, India

© Copyright 2025. All Rights Reserved by MedPath